- Home
- ARLP vs VKTX Comparison
ARLP vs VKTX Comparison
Compare ARLP & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARLP | VKTX |
|---|---|---|
| Founded | 1971 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ARLP | VKTX |
|---|---|---|
| Price | $25.78 | $35.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $29.50 | ★ $88.00 |
| AVG Volume (30 Days) | 340.8K | ★ 2.2M |
| Earning Date | 04-27-2026 | 04-22-2026 |
| Dividend Yield | ★ 9.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,002,857,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $3.57 | N/A |
| P/E Ratio | $10.68 | ★ N/A |
| Revenue Growth | ★ 11.50 | N/A |
| 52 Week Low | $22.53 | $21.23 |
| 52 Week High | $29.45 | $43.15 |
Technical Indicators
Market Signals| Indicator | ARLP | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.05 | 57.11 |
| Support Level | $24.68 | $33.65 |
| Resistance Level | $25.87 | $36.23 |
| Average True Range (ATR) | 0.78 | 1.93 |
| MACD | -0.35 | 0.20 |
| Stochastic Oscillator | 10.99 | 81.20 |
Price Performance
Historical ComparisonAbout ARLP Alliance Resource Partners L.P.
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties, and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex, and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II, and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties have included coal mineral reserves and resources owned or leased by Alliance Resource Properties.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.